Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.75 Insider Own31.54% Shs Outstand61.85M Perf Week-2.66%
Market Cap203.65M Forward P/E- EPS next Y-1.59 Insider Trans0.02% Shs Float42.38M Perf Month41.20%
Income-41.19M PEG- EPS next Q-0.16 Inst Own11.69% Short Float5.30% Perf Quarter91.28%
Sales0.00M P/S- EPS this Y10.81% Inst Trans-1.46% Short Ratio15.15 Perf Half Y64.50%
Book/sh-1.01 P/B- EPS next Y-140.91% ROA-165.97% Short Interest2.25M Perf Year78.80%
Cash/sh0.41 P/C7.94 EPS next 5Y- ROE- 52W Range1.28 - 4.27 Perf YTD98.19%
Dividend Est.- P/FCF- EPS past 5Y-14.30% ROI-357.52% 52W High-22.92% Beta0.76
Dividend TTM- Quick Ratio1.77 Sales past 5Y0.00% Gross Margin- 52W Low157.03% ATR (14)0.32
Dividend Ex-Date- Current Ratio1.77 EPS Y/Y TTM-13.92% Oper. Margin0.00% RSI (14)54.91 Volatility10.96% 11.40%
Employees14 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price11.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q9.67% Payout- Rel Volume1.09 Prev Close3.38
Sales Surprise- EPS Surprise-60.00% Sales Q/Q- EarningsMar 29 BMO Avg Volume148.17K Price3.29
SMA200.84% SMA5032.00% SMA20067.24% Trades Volume162,147 Change-2.66%
Date Action Analyst Rating Change Price Target Change
Aug-13-20Reiterated H.C. Wainwright Buy $9 → $12
Feb-13-19Initiated B. Riley FBR Buy $11
Dec-07-17Reiterated H.C. Wainwright Buy $6 → $10
Nov-28-17Reiterated H.C. Wainwright Buy $3.50 → $6
Oct-19-17Initiated ROTH Capital Buy
Mar-30-17Upgrade H.C. Wainwright Neutral → Buy $3.50
Oct-03-16Downgrade FBR & Co. Outperform → Mkt Perform $12 → $2
Sep-29-16Downgrade H.C. Wainwright Buy → Neutral $1.50
Sep-28-16Downgrade ROTH Capital Buy → Sell
Mar-28-16Resumed H.C. Wainwright Buy $8
Apr-09-24 08:00AM
Apr-05-24 08:52AM
Mar-29-24 09:11AM
Mar-12-24 08:00AM
11:11AM Loading…
Nov-13-23 11:11AM
Nov-03-23 08:00AM
Oct-23-23 08:00AM
Oct-12-23 08:00AM
Oct-03-23 08:00AM
Sep-26-23 08:00AM
Sep-13-23 05:22PM
Sep-11-23 09:55AM
08:00AM Loading…
Sep-07-23 12:00PM
Aug-17-23 12:00PM
Aug-14-23 08:00AM
May-18-23 04:37PM
May-15-23 08:00AM
Apr-27-23 08:00AM
Apr-18-23 08:00AM
Mar-30-23 08:00AM
Mar-16-23 08:00AM
Mar-02-23 08:00AM
Jan-24-23 08:00AM
Jan-05-23 08:00AM
Dec-13-22 09:55AM
Nov-29-22 08:00AM
08:00AM Loading…
Nov-28-22 08:00AM
Nov-14-22 08:00AM
Nov-01-22 08:00AM
Oct-14-22 08:00AM
Oct-12-22 08:00AM
Oct-06-22 08:00AM
Sep-08-22 08:00AM
Aug-15-22 08:00AM
Jul-26-22 08:00AM
Jun-21-22 08:00AM
May-23-22 08:00AM
May-16-22 08:00AM
May-11-22 11:20AM
May-03-22 08:30AM
Apr-15-22 07:20AM
Apr-14-22 08:00AM
Mar-31-22 08:00AM
Jan-06-22 08:00AM
Dec-21-21 08:00AM
Dec-13-21 08:00AM
Nov-15-21 08:00AM
Nov-05-21 04:24PM
Oct-27-21 08:00AM
Oct-05-21 03:39PM
Sep-21-21 08:00AM
Sep-09-21 09:00AM
Aug-30-21 08:00AM
Aug-16-21 09:00AM
Jul-30-21 04:28AM
Jul-09-21 09:25AM
Jun-13-21 11:23PM
May-17-21 08:00AM
Apr-27-21 09:28AM
Apr-19-21 08:00AM
Apr-15-21 09:00AM
Apr-14-21 08:28AM
Apr-13-21 07:01PM
Apr-06-21 08:00AM
Mar-31-21 08:00AM
Mar-08-21 08:00AM
Mar-04-21 08:00AM
Jan-31-21 02:28AM
Jan-19-21 11:15AM
Dec-11-20 08:00AM
Dec-04-20 04:17PM
Dec-01-20 08:00AM
Nov-09-20 08:00AM
Nov-02-20 08:02AM
Oct-12-20 08:11AM
Oct-06-20 03:30PM
Sep-29-20 12:00PM
Sep-22-20 08:04AM
Sep-10-20 08:00AM
Sep-09-20 11:46AM
Sep-02-20 08:00AM
Aug-10-20 08:00AM
Aug-03-20 12:48PM
Jun-30-20 09:05AM
Jun-04-20 09:48PM
May-22-20 08:17AM
May-11-20 08:00AM
May-04-20 08:37AM
Apr-30-20 09:00AM
Apr-02-20 08:04AM
Mar-16-20 08:00AM
Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FREEMAN KEVIN DDirectorApr 22 '24Buy2.982,5007,45025,969Apr 22 04:04 PM
ELDRED KARYDirectorJan 16 '24Buy1.7950089349,313Jan 16 11:23 AM
Uihlein Richard EDirectorSep 26 '23Option Exercise4.492,236,20410,033,02010,235,495Sep 27 02:03 PM
ELDRED KARYDirectorJul 19 '23Buy1.791,5982,85448,813Jul 20 07:40 AM